Bessemer Group
TNGX icon

Bessemer Group’s Tango Therapeutics TNGX Stock Holding History

Bessemer Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8M Hold
708,398
– – 0.02% 308
2025
Q4 		$6.28M Hold
708,398
– – 0.01% 376
2025
Q3 		$5.95M Buy
708,398
+14
+0% +$95 0.01% 345
2025
Q2 		$3.63M Hold
708,384
– – 0.01% 395
2025
Q1 		$970K Hold
708,384
– – ﹤0.01% 710
2024
Q4 		$2.19M Hold
708,384
– – ﹤0.01% 630
2024
Q3 		$5.46M Hold
708,384
– – 0.01% 403
2024
Q2 		$6.08M Hold
708,384
– – 0.01% 347
2024
Q1 		$5.63M Hold
708,384
– – 0.01% 371
2023
Q4 		$7.01M Hold
708,384
– – 0.01% 338
2023
Q3 		$7.98M Hold
708,384
– – 0.02% 292
2023
Q2 		$2.35M Hold
708,384
– – 0.01% 461
2023
Q1 		$2.8M Hold
708,384
– – 0.01% 410
2022
Q4 		$5.14M Hold
708,384
– – 0.01% 328
2022
Q3 		$2.56M Hold
708,384
– – 0.01% 406
2022
Q2 		$3.21M Buy
+708,384
New +$4.29M 0.01% 367

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Bessemer Group's TNGX Position: Q1 2026 in Review

Bessemer Group held its Tango Therapeutics (TNGX) position steady in Q1 2026 at 708,398 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #308.

Bessemer Group first reported a position in TNGX in Q2 2022 and has held it in 16 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Bessemer Group held 708,398 shares of Tango Therapeutics worth $14.8M as of Q1 2026.
  • Bessemer Group left its Tango Therapeutics share count unchanged in Q1 2026.
  • Tango Therapeutics made up 0.02% of Bessemer Group's portfolio in Q1 2026, its #308 holding.
  • Bessemer Group first reported a position in Tango Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.